⌘K
Umoja Biopharma
Healthcare & Life Sciences
Recent Finacing
Series C
Recent Raise
$100M
Umoja Biopharma is a biotechnology company focused on developing in vivo CAR T cell therapies for oncology and autoimmune diseases using its VivoVec™ gene delivery technology.
Focus Areas
Biotechnology
In vivo cell therapies
CAR T cell therapy
Oncology
Autoimmune diseases
Gene delivery technology
Investors
